Telomere length is maintained by telomerase in 90% of human cancers, while 10% of cancers utilize an alternative mechanism of telomere lengthening termed ALT (Kim et al., 1994; Bryan et al., 1995, 1997; Shay and Bacchetti, 1997). The gene discussed is GPT; the disease is cancer.